Skip Navigation

Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring STMDDM versus Usual Care in Patients with Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer

Brief Summary

Type:
Breast Cancer

Study Type:
Health Services

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT03723928

Study #:
STUDY00145181

Start Date:
Feb 14, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03723928

View Complete Trial Details & Eligibility at ClinicalTrials.gov